Determination of clinically significant tests for antiphospholipid antibodies and cutoff levels for obstetric antiphospholipid syndrome

Lupus

Volumn 24, Issue 14, 2015, Pages 1505-1519

  Kitaori, T ^a   Sugiura Ogasawara, M ^a   Oku, K ^b   Papisch, W ^c   Ebara, T ^a   Ozaki, Y ^a   Katano, K ^a   Atsumi, T ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Antiphospholipid antibodies; lupus anticoagulant; phosphatidylserine dependent antiprothrombin antibody; recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; DIAGNOSTIC KIT;

ADULT; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; BLOOD CLOTTING TIME; CLINICAL PRACTICE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GYNECOLOGIC DISEASE; HUMAN; IMMUNOASSAY; LIVE BIRTH; LOW DRUG DOSE; LUPUS ANTICOAGULANT ACTIVE PARTIAL THROMBOPLASTIN TIME ASSAY; LUPUS ANTICOAGULANT ACTIVE PARTIAL THROMBOPLASTIN TIME STACLOT ASSAY; LUPUS ANTICOAGULANT DILUTE RUSSEL VIPER VENOM TIME ASSAY; MAJOR CLINICAL STUDY; OBSTETRIC ANTIPHOSPHOLIPID SYNDROME; OBSTETRIC PATIENT; PARTIAL THROMBOPLASTIN TIME; PHOSPHATIDYLSERINE DEPENDENT ANTIPROTHROMBIN ASSAY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; BLOOD; DIAGNOSTIC KIT; IMMUNOLOGY; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY RATE; PROCEDURES; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY RATE; REAGENT KITS, DIAGNOSTIC;

EID: 84947284973     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315595128     Document Type: Article

References (33)

1. Farquharson RG, Pearson JF, John L,. Lupus anticoagulant and pregnancy management. Lancet 1984; 2: 228-229.
2. Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K,. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil Steril 2004; 81: 367-373.
3. Sugiura-Ogasawara M, Ozaki Y, Kitaori T, Kumagai K, Suzuki S,. Midline uterine defect size correlated with miscarriage of euploid embryos in recurrent cases. Fertil Steril 2010; 93: 1983-1988.
4. Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Kitaori T, Mizutani E,. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 2012; 27: 2297-2303.
5. Branch DW, Gibson M, Silver RM,. Clinical practice: Recurrent miscarriage. N Engl J Med 2010; 363: 1740-1747.
6. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L,. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318-1323.
7. Rai R, Cohen H, Dave M, Regan L,. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.
8. Kutteh WH,. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
9. Ziakas PD, Pavlou M, Voulgarelis M,. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta-analysis. Obstet Gynecol 2010; 115: 1256-1262.
10. Clark CA, Laskin CA, Spitzer KA,. Anticardiolipin antibodies and recurrent early pregnancy loss: A century of equivocal evidence. Hum Reprod Update 2012; 18: 474-484.
11. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
12. Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASA Trial. J Rheumatol 2009; 36: 279-287.
13. Ogasawara M, Aoki K, Kajiura S, Yagami Y,. Are antinuclear antibodies predictive of recurrent miscarriages?. Lancet 1996; 347: 1183-1184.
14. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa I, Koike T,. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178.
15. Roubey RA,. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulant and other antiphospholipid autoantibodies. Blood 1994; 84: 2854-2867.
16. Sugi T, McIntyre JA,. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86: 3083-3089.
17. Katano K, Aoki K, Sasa H, Ogasawara M, Matsuura E, Yagami Y,. β2glycoproteinI-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996; 11: 509-512.
18. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y,. Anti β2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: Prevalence and clinical significance. Lupus 1996; 5: 587-592.
19. Sugiura-Ogasawara M, Ozaki Y, Nakanishi T, Sato T, Suzumori N, Nozawa K,. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: A retrospective cohort-control study. Am J Reprod Immunol 2008; 59: 235-241.
20. Kaandorp SP, Goddijn M, van der Post JAM, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586-1596.
21. Atsumi T, Ieko M, Bertolaccini ML, et al. Association of autoantibodies against the phosohatidylserine-prothrombin complex with manifestations of antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982-1993.
22. Harris EN, Gharavi AE, Patel BM, Hughes GR,. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
23. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T,. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-462.
24. Jaskowski TD, Wilson AR, Hill HR, Branch WD, Tebo AE,. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome?. Clin Chim Acta 2009; 410: 19-24.
25. Sugiura-Ogasawara M, Atsumi T, Ozaki Y, Koike T, Suzumori K,. Phosphatidylserine-dependent antiprothrombin antibodies are not useful markers for high-risk women with recurrent miscarriages. Fertil Steril 2004; 82: 1440-1442.
26. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC,. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369-373.
27. Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 2009; 79: 188-195.
28. Obayashi S, Ozaki Y, Sugi T, Kitaori T, Suzuki S, Sugiura-Ogasawara M,. Antiphosphatidylethanolamine antibodies might not be independent risk factors for further miscarriage in patients suffering recurrent pregnancy loss. J Reprod Immunol 2010; 85: 41-45.
29. Sugi T, Katsunuma J, Izumi S, McIntyre JA, Makino T,. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril 1999; 71: 1060-1065.
30. Sanmarco M, Gayet S, Alessi MC, et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost 2007; 97: 949-954.
31. Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012; 64: 2311-2318.
32. Harris EN, Spinnato JA,. Should anticardiolipin tests be performed in otherwise healthy pregnant women?. Am J Obstet Gynecol 1991; 165: 1272-1277.
33. Otomo K, Atsumi T, Amengual O, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum 2012; 64: 504-512.